Machine learning algorithm outperforms fibrosis markers in predicting significant fibrosis in biopsy‐confirmed NAFLD

G Feng, KI Zheng, YY Li, RS Rios… - Journal of Hepato …, 2021 - Wiley Online Library
Background The presence of significant liver fibrosis is a key determinant of long‐term
prognosis in non‐alcoholic fatty liver disease (NAFLD). We aimed to develop a novel …

Individualized risk prediction of significant fibrosis in non-alcoholic fatty liver disease using a novel nomogram

YJ Zhou, FZ Ye, YY Li, XY Pan… - United European …, 2019 - journals.sagepub.com
Background Fibrosis is deemed to be a pivotal determinant of the long-term prognosis in
non-alcoholic fatty liver disease (NAFLD). Objective We aimed to develop a novel …

Step layered combination of noninvasive fibrosis models improves diagnostic accuracy of advanced fibrosis in nonalcoholic fatty liver disease.

M Yang, L Jiang, Y Wang, X Li, G Zhou… - … of Gastrointestinal & …, 2019 - search.ebscohost.com
Abstract Background & Aims: Liver fibrosis is stage-dependently associated with non-
alcoholic fatty liver disease (NAFLD) progression. The increased awareness of non-invasive …

Diagnosis of fibrosis using blood markers and logistic regression in southeast asian patients with non-alcoholic fatty liver disease

C Sang, H Yan, WK Chan, X Zhu, T Sun… - Frontiers in …, 2021 - frontiersin.org
Non-alcoholic fatty liver disease (NAFLD) is one of the main causes of fibrosis. Liver biopsy
remains the gold standard for the confirmation of fibrosis in NAFLD patients. Effective and …

Diagnostic accuracy of noninvasive fibrosis models to detect change in fibrosis stage

MS Siddiqui, G Yamada, R Vuppalanchi… - Clinical …, 2019 - Elsevier
Background & Aims Noninvasive methods are needed to determine disease stage in
patients with nonalcoholic fatty liver disease (NAFLD). We evaluated the diagnostic …

NIKEI: a new inexpensive and non-invasive scoring system to exclude advanced fibrosis in patients with NAFLD

M Demir, S Lang, M Schlattjan, U Drebber… - PLoS …, 2013 - journals.plos.org
Aims To develop, validate and compare a non-invasive fibrosis scoring system for non-
alcoholic fatty liver disease (NAFLD) derived from routinely obtained clinical and …

[HTML][HTML] MRE is superior to ARFI for the diagnosis of fibrosis in patients with biopsy-proven NAFLD: a prospective study

J Cui, E Heba, C Hernandez, W Haufe… - Hepatology …, 2016 - ncbi.nlm.nih.gov
Magnetic resonance elastography (MRE), an advanced MR-based imaging technique, and
acoustic radiation force impulse (ARFI), an ultrasound-based imaging technique, have been …

Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study

A Goyale, A Jain, C Smith, M Papatheodoridi… - PLoS …, 2021 - journals.plos.org
Background/Aims Non-alcoholic fatty liver disease (NAFLD) represents a significant public
health issue. Identifying patients with simple steatosis from those with non-alcoholic …

Development of serum marker models to increase diagnostic accuracy of advanced fibrosis in nonalcoholic fatty liver disease: the new LINKI algorithm compared with …

B Lykiardopoulos, H Hagström, M Fredrikson… - PloS one, 2016 - journals.plos.org
Background and Aim Detection of advanced fibrosis (F3-F4) in nonalcoholic fatty liver
disease (NAFLD) is important for ascertaining prognosis. Serum markers have been …

Association of non-invasive markers with significant fibrosis in patients with nonalcoholic fatty liver disease: a cross-sectional study

F Zhang, Y Han, L Zheng, J Liu, Y Wu… - Diabetes, Metabolic …, 2023 - Taylor & Francis
Purpose The identification of significant fibrosis is critical for predicting the prognosis of non-
alcoholic fatty liver disease (NAFLD). This study aimed to compare the predictive value of …